Real-time enrollment status for this melanoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 3:34 PM UTC
| NCT Number | NCT05361174 |
| Recruiting Status | Recruiting |
| Condition | Melanoma |
| Phase | PHASE1 |
| Target Enrollment | 53 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Iovance Biotherapeutics, Inc. |
| Last Updated on CT.gov | June 11, 2026 (Jun 11, 2026) |
As of July 19, 2026: Clinical trial NCT05361174 is currently recruiting participants. This phase1 study for melanoma is actively seeking new participants at 11 locations across the United States. The study is sponsored by Iovance Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05361174 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05361174 was last updated Jun 11, 2026 (June 11, 2026). HelloStudys verifies this status automatically.